These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15614933)

  • 1. State of the art for digestive organs. Proceedings of the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. November 14-15, 2003. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S1-90. PubMed ID: 15614933
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in Cancer Metastasis. Proceedings of the 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 11-12 September 1998.
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S1-103. PubMed ID: 10375280
    [No Abstract]   [Full Text] [Related]  

  • 3. New concepts of treatment strategies for hormone-related cancer. Proceedings of the 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. March 11-12, 2005. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():1-99. PubMed ID: 16273362
    [No Abstract]   [Full Text] [Related]  

  • 4. New therapeutic strategies for higher cure rates: high dose therapy and new therapeutic modalities. Proceedings of the 12th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 4-5 October 1996.
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S1-118. PubMed ID: 9289398
    [No Abstract]   [Full Text] [Related]  

  • 5. The 11th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Cytokines and New Anticancer Agents on the Horizon of Oncology. Nagoya, Japan, 24-25 November 1995.
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S1-119. PubMed ID: 8777775
    [No Abstract]   [Full Text] [Related]  

  • 6. [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
    Ebert MP; Schmid RM
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1835-7. PubMed ID: 19728255
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Cancers--2007 symposium. Multidisciplinary approaches to the prevention, diagnosis and therapy of GI cancers.
    Matysiak T
    IDrugs; 2007 Mar; 10(3):159-61. PubMed ID: 17351865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are the "4P" clinical strategies against gastrointestinal tumors still far away?].
    Gao HJ; Guo Y
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):286-7. PubMed ID: 20627030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary gastrointestinal lymphomas].
    Graca M; Jamski J; Pałka G; Krzesiwo-Stempak K
    Przegl Lek; 1999; 56(7-8):483-6. PubMed ID: 10575913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
    Demetri G; DeMatteo RP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
    [No Abstract]   [Full Text] [Related]  

  • 12. ESMO World Congress on Gastrointestinal Cancer 2016.
    Carlson R
    Lancet Oncol; 2016 Aug; 17(8):1040. PubMed ID: 27397042
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carcinoma of the pancreas: adjuvant and neoadjuvant treatment].
    Enrici RM; Santoro M
    Suppl Tumori; 2002; 1(3):S18-21. PubMed ID: 12415780
    [No Abstract]   [Full Text] [Related]  

  • 14. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
    Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U
    Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal cancer: advances in diagnostic techniques and therapy.
    Front Gastrointest Res; 1979; 5():1-225. PubMed ID: 499974
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.
    Jafari M; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):751-60, xi. PubMed ID: 15350946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.
    Lordick F; Ruers T; Aust DE; Collette L; Downey RJ; El Hajjam M; Flamen P; Haustermans K; Ilson D; Julié C; Krause BJ; Newiger H; Ott K; Roth A; Van Cutsem E; Weber WA; Lutz MP;
    Eur J Cancer; 2008 Sep; 44(13):1807-19. PubMed ID: 18640028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chemotherapy in patients with soft tissue sarcomas.
    Maki RG
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has progress been made in gastrointestinal cancer treatment?
    Glimelius B
    Acta Oncol; 2002; 41(2):115-7. PubMed ID: 12102153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.